Dr. Jacob Levitt, MD

Dr. Levitt practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Levitt's NPI, 1568457679, was assigned on September 14, 2005. Dr. Levitt graduated from Albert Einstein College of Medicine of Yeshiva University in 2000. Dr. Levitt holds New York license 222218.

Dr. Levitt's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Levitt also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Levitt's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Levitt is also affiliated with NYC Health + Hospitals/Metropolitan. The medical group on file is The Dermatology Specialists. Dmand AI also links Dr. Levitt to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levitt practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Levitt's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Levitt is licensed in New York.

CMS data shows 164 Medicare services from Dr. Levitt across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $13,945 for them. Every service was in an office.

CMS counts 82 Medicare patients who saw Dr. Levitt in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levitt's median patient age at 45, with 55% women.

In 2024, Dr. Levitt wrote 786 Medicare Part D claims for 125 patients. 56% of them were for generic drugs. CMS names the drug for 452 of them, across 24 drugs with 11 or more claims each, at $767,979 in total drug cost. In 2023, CMS named 541 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 37 out of 100 for Dr. Levitt for performance year 2024, reported as part of a group. Dr. Levitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of removal of skin lesions by Dr. Levitt, more than 72% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 65 papers to Dr. Levitt, published from 2011 to 2023. 2020 was the busiest year, with 7. The most frequent topics are Dermatologic Agents, Dermatology and Immunosuppressive Agents. Dr. Levitt has published most often in Dermatol Online J. Dr. Levitt's most frequent co-authors are Cindy Lina Tsui, Aakaash Varma, MD and Gillian Meade Heinecke, MD.

CMS Open Payments shows 672 general payments to Dr. Levitt from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Novartis Pharmaceuticals Corporation paid the most, $35,834.

Dr. Levitt graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.